Chimerix, Inc. , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that it will report financial results for the third quarter ended September 30, 2013, on Thursday, November 14, 2013, before the market opens.
http://www.globenewswire.com/news-release/2013/11/05/587010/10056427/en/Chimerix-to-Report-Third-Quarter-Financial-Results-on-November-14-2013.html
http://www.globenewswire.com/news-release/2013/11/05/587010/10056427/en/Chimerix-to-Report-Third-Quarter-Financial-Results-on-November-14-2013.html
No comments:
Post a Comment